APO Research

APO RESEARCH · REPORT

Filgotinib Tablets

Selected research

Industry Growth & Trends

Global Filgotinib Tablets Industry Growth and Trends Forecast to 2032

Market perspective

The global Filgotinib Tablets market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Filgotinib Tablets is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Filgotinib Tablets is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Filgotinib Tablets is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Filgotinib Tablets include Alfasigma, Gilead Sciences and Eisai, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Filgotinib Tablets market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Filgotinib Tablets market size, estimates, and forecasts are presented in terms of sales volume (K Units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Filgotinib Tablets market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Filgotinib Tablets.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Filgotinib Tablets market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Filgotinib Tablets Market by Company

Alfasigma

Gilead Sciences

Eisai

Filgotinib Tablets Segment by Type

100mg per Tablet

200mg per Tablet

Filgotinib Tablets Segment by Application

Hospital Pharmacy

Online Pharmacy

Retail Pharmacy

Filgotinib Tablets Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Filgotinib Tablets market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Filgotinib Tablets and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Filgotinib Tablets.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Filgotinib Tablets manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Filgotinib Tablets in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of 100mg per Tablet Table 2. Major Company of 200mg per Tablet Table 3. Global Filgotinib Tablets Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 4. Global Filgotinib Tablets Sales by Type (2021-2026) & (K Units) Table 5. Global Filgotinib Tablets Sales Market Share in Volume by Type (2021-2026) Table 6. Global Filgotinib Tablets Sales by Type (2021-2026) & (US$ Million) Table 7. Global Filgotinib Tablets Sales Market Share in Value by Type (2021-2026) Table 8. Global Filgotinib Tablets Price by Type (2021-2026) & (US$/Unit) Table 9. Global Filgotinib Tablets Sales by Type (2027-2032) & (K Units) Table 10. Global Filgotinib Tablets Sales Market Share in Volume by Type (2027-2032) Table 11. Global Filgotinib Tablets Sales by Type (2027-2032) & (US$ Million) Table 12. Global Filgotinib Tablets Sales Market Share in Value by Type (2027-2032) Table 13. Global Filgotinib Tablets Price by Type (2027-2032) & (US$/Unit) Table 14. North America Filgotinib Tablets Sales by Type (2021-2026) & (K Units) Table 15. North America Filgotinib Tablets Sales by Type (2021-2026) & (US$ Million) Table 16. Europe Filgotinib Tablets Sales by Type (2021-2026) & (K Units) Table 17. Europe Filgotinib Tablets Sales by Type (2021-2026) & (US$ Million) Table 18. Asia-Pacific Filgotinib Tablets Sales by Type (2021-2026) & (K Units) Table 19. Asia-Pacific Filgotinib Tablets Sales by Type (2021-2026) & (US$ Million) Table 20. Latin America Filgotinib Tablets Sales by Type (2021-2026) & (K Units) Table 21. Latin America Filgotinib Tablets Sales by Type (2021-2026) & (US$ Million) Table 22. Middle East and Africa Filgotinib Tablets Sales by Type (2021-2026) & (K Units) Table 23. Middle East and Africa Filgotinib Tablets Sales by Type (2021-2026) & (US$ Million) Table 24. Filgotinib Tablets Industry Trends Table 25. Filgotinib Tablets Industry Drivers Table 26. Filgotinib Tablets Industry Opportunities and Challenges Table 27. Filgotinib Tablets Industry Restraints Table 28. Global Filgotinib Tablets Sales Revenue by Company (US$ Million) & (2021-2026) Table 29. Global Filgotinib Tablets Revenue Market Share by Company (2021-2026) Table 30. Global Filgotinib Tablets Sales by Company (2021-2026) & (K Units) Table 31. Global Filgotinib Tablets Sales Share by Company (2021-2026) Table 32. Global Filgotinib Tablets Market Price by Company (2021-2026) & (US$/Unit) Table 33. Global Filgotinib Tablets Industry Company Ranking, 2024 VS 2025 VS 2026 Table 34. Global Filgotinib Tablets Major Company Production Sites and Headquarters Table 35. Global Filgotinib Tablets Company, Product Type & Application Table 36. Global Filgotinib Tablets Company Establishment Date Table 37. Global Company Market Concentration Ratio (CR5 and HHI) Table 38. Global Filgotinib Tablets by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 39. Global Filgotinib Tablets Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 40. Global Filgotinib Tablets Sales by Region (2021-2026) & (K Units) Table 41. Global Filgotinib Tablets Sales Market Share in Volume by Region (2021-2026) Table 42. Global Filgotinib Tablets Sales by Region (2021-2026) & (US$ Million) Table 43. Global Filgotinib Tablets Sales Market Share in Value by Region (2021-2026) Table 44. Global Filgotinib Tablets Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 45. Global Filgotinib Tablets Sales by Region (2027-2032) & (K Units) Table 46. Global Filgotinib Tablets Sales Market Share in Volume by Region (2027-2032) Table 47. Global Filgotinib Tablets Sales by Region (2027-2032) & (US$ Million) Table 48. Global Filgotinib Tablets Sales Market Share in Value by Region (2027-2032) Table 49. Global Filgotinib Tablets Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2027-2032) Table 50. Global Filgotinib Tablets Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 51. Global Filgotinib Tablets Sales by Application (2021-2026) & (K Units) Table 52. Global Filgotinib Tablets Sales Market Share in Volume by Application (2021-2026) Table 53. Global Filgotinib Tablets Sales by Application (2021-2026) & (US$ Million) Table 54. Global Filgotinib Tablets Sales Market Share in Value by Application (2021-2026) Table 55. Global Filgotinib Tablets Price by Application (2021-2026) & (US$/Unit) Table 56. Global Filgotinib Tablets Sales by Application (2027-2032) & (K Units) Table 57. Global Filgotinib Tablets Sales Market Share in Volume by Application (2027-2032) Table 58. Global Filgotinib Tablets Sales by Application (2027-2032) & (US$ Million) Table 59. Global Filgotinib Tablets Sales Market Share in Value by Application (2027-2032) Table 60. Global Filgotinib Tablets Price by Application (2027-2032) & (US$/Unit) Table 61. North America Filgotinib Tablets Sales by Application (2021-2026) & (K Units) Table 62. North America Filgotinib Tablets Sales by Application (2021-2026) & (US$ Million) Table 63. Europe Filgotinib Tablets Sales by Application (2021-2026) & (K Units) Table 64. Europe Filgotinib Tablets Sales by Application (2021-2026) & (US$ Million) Table 65. Asia-Pacific Filgotinib Tablets Sales by Application (2021-2026) & (K Units) Table 66. Asia-Pacific Filgotinib Tablets Sales by Application (2021-2026) & (US$ Million) Table 67. Latin America Filgotinib Tablets Sales by Application (2021-2026) & (K Units) Table 68. Latin America Filgotinib Tablets Sales by Application (2021-2026) & (US$ Million) Table 69. Middle East and Africa Filgotinib Tablets Sales by Application (2021-2026) & (K Units) Table 70. Middle East and Africa Filgotinib Tablets Sales by Application (2021-2026) & (US$ Million) Table 71. Alfasigma Company Information Table 72. Alfasigma Business Overview Table 73. Alfasigma Filgotinib Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 74. Alfasigma Filgotinib Tablets Product Portfolio Table 75. Alfasigma Recent Development Table 76. Gilead Sciences Company Information Table 77. Gilead Sciences Business Overview Table 78. Gilead Sciences Filgotinib Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 79. Gilead Sciences Filgotinib Tablets Product Portfolio Table 80. Gilead Sciences Recent Development Table 81. Eisai Company Information Table 82. Eisai Business Overview Table 83. Eisai Filgotinib Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 84. Eisai Filgotinib Tablets Product Portfolio Table 85. Eisai Recent Development Table 86. North America Filgotinib Tablets Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 87. North America Filgotinib Tablets Sales by Country (2021-2026) & (K Units) Table 88. North America Filgotinib Tablets Sales Market Share by Country (2021-2026) Table 89. North America Filgotinib Tablets Sales Forecast by Country (2027-2032) & (K Units) Table 90. North America Filgotinib Tablets Sales Market Share Forecast by Country (2027-2032) Table 91. North America Filgotinib Tablets Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 92. North America Filgotinib Tablets Market Size by Country (2021-2026) & (US$ Million) Table 93. North America Filgotinib Tablets Market Share by Country (2021-2026) Table 94. North America Filgotinib Tablets Market Size Forecast by Country (2027-2032) & (US$ Million) Table 95. North America Filgotinib Tablets Market Share Forecast by Country (2027-2032) Table 96. Europe Filgotinib Tablets Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 97. Europe Filgotinib Tablets Sales by Country (2021-2026) & (K Units) Table 98. Europe Filgotinib Tablets Sales Market Share by Country (2021-2026) Table 99. Europe Filgotinib Tablets Sales Forecast by Country (2027-2032) & (K Units) Table 100. Europe Filgotinib Tablets Sales Market Share Forecast by Country (2027-2032) Table 101. Europe Filgotinib Tablets Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 102. Europe Filgotinib Tablets Market Size by Country (2021-2026) & (US$ Million) Table 103. Europe Filgotinib Tablets Market Share by Country (2021-2026) Table 104. Europe Filgotinib Tablets Market Size Forecast by Country (2027-2032) & (US$ Million) Table 105. Europe Filgotinib Tablets Market Share Forecast by Country (2027-2032) Table 106. Asia-Pacific Filgotinib Tablets Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 107. Asia-Pacific Filgotinib Tablets Sales by Country (2021-2026) & (K Units) Table 108. Asia-Pacific Filgotinib Tablets Sales Market Share by Country (2021-2026) Table 109. Asia-Pacific Filgotinib Tablets Sales Forecast by Country (2027-2032) & (K Units) Table 110. Asia-Pacific Filgotinib Tablets Sales Market Share Forecast by Country (2027-2032) Table 111. Asia-Pacific Filgotinib Tablets Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 112. Asia-Pacific Filgotinib Tablets Market Size by Country (2021-2026) & (US$ Million) Table 113. Asia-Pacific Filgotinib Tablets Market Share by Country (2021-2026) Table 114. Asia-Pacific Filgotinib Tablets Market Size Forecast by Country (2027-2032) & (US$ Million) Table 115. Asia-Pacific Filgotinib Tablets Market Share Forecast by Country (2027-2032) Table 116. Latin America Filgotinib Tablets Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 117. Latin America Filgotinib Tablets Sales by Country (2021-2026) & (K Units) Table 118. Latin America Filgotinib Tablets Sales Market Share by Country (2021-2026) Table 119. Latin America Filgotinib Tablets Sales Forecast by Country (2027-2032) & (K Units) Table 120. Latin America Filgotinib Tablets Sales Market Share Forecast by Country (2027-2032) Table 121. Latin America Filgotinib Tablets Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 122. Latin America Filgotinib Tablets Market Size by Country (2021-2026) & (US$ Million) Table 123. Latin America Filgotinib Tablets Market Share by Country (2021-2026) Table 124. Latin America Filgotinib Tablets Market Size Forecast by Country (2027-2032) & (US$ Million) Table 125. Latin America Filgotinib Tablets Market Share Forecast by Country (2027-2032) Table 126. Middle East and Africa Filgotinib Tablets Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 127. Middle East and Africa Filgotinib Tablets Sales by Country (2021-2026) & (K Units) Table 128. Middle East and Africa Filgotinib Tablets Sales Market Share by Country (2021-2026) Table 129. Middle East and Africa Filgotinib Tablets Sales Forecast by Country (2027-2032) & (K Units) Table 130. Middle East and Africa Filgotinib Tablets Sales Market Share Forecast by Country (2027-2032) Table 131. Middle East and Africa Filgotinib Tablets Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 132. Middle East and Africa Filgotinib Tablets Market Size by Country (2021-2026) & (US$ Million) Table 133. Middle East and Africa Filgotinib Tablets Market Share by Country (2021-2026) Table 134. Middle East and Africa Filgotinib Tablets Market Size Forecast by Country (2027-2032) & (US$ Million) Table 135. Middle East and Africa Filgotinib Tablets Market Share Forecast by Country (2027-2032) Table 136. Key Raw Materials Table 137. Raw Materials Key Suppliers Table 138. Filgotinib Tablets Distributors List Table 139. Filgotinib Tablets Customers List Table 140. Research Programs/Design for This Report Table 141. Authors List of This Report Table 142. Secondary Sources Table 143. Primary Sources List of Figures Figure 1. Filgotinib Tablets Image Figure 2. Global Filgotinib Tablets Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Filgotinib Tablets Market Size (2021-2032) & (US$ Million) Figure 4. Global Filgotinib Tablets Sales (2021-2032) & (K Units) Figure 5. 100mg per Tablet Image Figure 6. Global 100mg per Tablet Sales YoY Growth (2021-2032) & (K Units) Figure 7. 200mg per Tablet Image Figure 8. Global 200mg per Tablet Sales YoY Growth (2021-2032) & (K Units) Figure 9. Global Filgotinib Tablets Market Size Overview by Type (2021-2032) & (US$ Million) Figure 10. Global Filgotinib Tablets Market Share by Type 2025 VS 2032 Figure 11. North America Filgotinib Tablets Sales Market Share in Volume by Type in 2025 Figure 12. North America Filgotinib Tablets Sales Market Share in Value by Type in 2025 Figure 13. Europe Filgotinib Tablets Sales Market Share in Volume by Type in 2025 Figure 14. Europe Filgotinib Tablets Sales Market Share in Value by Type in 2025 Figure 15. Asia-Pacific Filgotinib Tablets Sales Market Share in Volume by Type in 2025 Figure 16. Asia-Pacific Filgotinib Tablets Sales Market Share in Value by Type in 2025 Figure 17. Latin America Filgotinib Tablets Sales Market Share in Volume by Type in 2025 Figure 18. Latin America Filgotinib Tablets Sales Market Share in Value by Type in 2025 Figure 19. Middle East and Africa Filgotinib Tablets Sales Market Share in Volume by Type in 2025 Figure 20. Middle East and Africa Filgotinib Tablets Sales Market Share in Value by Type in 2025 Figure 21. Global Top 5 and 10 Filgotinib Tablets Players Market Share by Revenue in 2025 Figure 22. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 23. Hospital Pharmacy Image Figure 24. Global Hospital Pharmacy Sales YoY Growth (2021-2032) & (K Units) Figure 25. Online Pharmacy Image Figure 26. Global Online Pharmacy Sales YoY Growth (2021-2032) & (K Units) Figure 27. Retail Pharmacy Image Figure 28. Global Retail Pharmacy Sales YoY Growth (2021-2032) & (K Units) Figure 29. Global Filgotinib Tablets Market Size Overview by Application (2021-2032) & (US$ Million) Figure 30. Global Filgotinib Tablets Market Share by Application 2025 VS 2032 Figure 31. North America Filgotinib Tablets Sales Market Share in Volume by Application in 2025 Figure 32. North America Filgotinib Tablets Sales Market Share in Value by Application in 2025 Figure 33. Europe Filgotinib Tablets Sales Market Share in Volume by Application in 2025 Figure 34. Europe Filgotinib Tablets Sales Market Share in Value by Application in 2025 Figure 35. Asia-Pacific Filgotinib Tablets Sales Market Share in Volume by Application in 2025 Figure 36. Asia-Pacific Filgotinib Tablets Sales Market Share in Value by Application in 2025 Figure 37. Latin America Filgotinib Tablets Sales Market Share in Volume by Application in 2025 Figure 38. Latin America Filgotinib Tablets Sales Market Share in Value by Application in 2025 Figure 39. Middle East and Africa Filgotinib Tablets Sales Market Share in Volume by Application in 2025 Figure 40. Middle East and Africa Filgotinib Tablets Sales Market Share in Value by Application in 2025 Figure 41. North America Filgotinib Tablets Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 42. North America Filgotinib Tablets Sales Share by Country: 2021 VS 2025 VS 2032 Figure 43. North America Filgotinib Tablets Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 44. North America Filgotinib Tablets Market Share by Country: 2021 VS 2025 VS 2032 Figure 45. Europe Filgotinib Tablets Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 46. Europe Filgotinib Tablets Sales Share by Country: 2021 VS 2025 VS 2032 Figure 47. Europe Filgotinib Tablets Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 48. Europe Filgotinib Tablets Market Share by Country: 2021 VS 2025 VS 2032 Figure 49. Asia-Pacific Filgotinib Tablets Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 50. Asia-Pacific Filgotinib Tablets Sales Share by Country: 2021 VS 2025 VS 2032 Figure 51. Asia-Pacific Filgotinib Tablets Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 52. Asia-Pacific Filgotinib Tablets Market Share by Country: 2021 VS 2025 VS 2032 Figure 53. Latin America Filgotinib Tablets Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 54. Latin America Filgotinib Tablets Sales Share by Country: 2021 VS 2025 VS 2032 Figure 55. Latin America Filgotinib Tablets Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 56. Latin America Filgotinib Tablets Market Share by Country: 2021 VS 2025 VS 2032 Figure 57. Middle East and Africa Filgotinib Tablets Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 58. Middle East and Africa Filgotinib Tablets Sales Share by Country: 2021 VS 2025 VS 2032 Figure 59. Middle East and Africa Filgotinib Tablets Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 60. Middle East and Africa Filgotinib Tablets Market Share by Country: 2021 VS 2025 VS 2032 Figure 61. Filgotinib Tablets Value Chain Figure 62. Key Raw Materials Price Figure 63. Manufacturing Cost Structure Figure 64. Filgotinib Tablets Production Mode & Process Figure 65. Direct Comparison with Distribution Share Figure 66. Distributors Profiles Figure 67. Years Considered Figure 68. Research Process Figure 69. Key Executives Interviewed

Scope & coverage.

Types
  • 100mg per Tablet
  • 200mg per Tablet
Applications
  • Hospital Pharmacy
  • Online Pharmacy
  • Retail Pharmacy
Companies covered
  • Alfasigma
  • Gilead Sciences
  • Eisai

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Filgotinib Tablets Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Filgotinib Tablets Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Filgotinib Tablets Market by Type
  6. 1.3.1 100mg per Tablet
  7. 1.3.2 200mg per Tablet
  8. 1.4 Global Filgotinib Tablets Market Size by Type
  9. 1.4.1 Global Filgotinib Tablets Market Size Overview by Type (2021-2032)
  10. 1.4.2 Global Filgotinib Tablets Historic Market Size Review by Type (2021-2026)
  11. 1.4.3 Global Filgotinib Tablets Forecasted Market Size by Type (2027-2032)
  12. 1.5 Key Regions Market Size by Type
  13. 1.5.1 North America Filgotinib Tablets Sales Breakdown by Type (2021-2026)
  14. 1.5.2 Europe Filgotinib Tablets Sales Breakdown by Type (2021-2026)
  15. 1.5.3 Asia-Pacific Filgotinib Tablets Sales Breakdown by Type (2021-2026)
  16. 1.5.4 South America Filgotinib Tablets Sales Breakdown by Type (2021-2026)
  17. 1.5.5 Middle East and Africa Filgotinib Tablets Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Filgotinib Tablets Industry Trends
  2. 2.2 Filgotinib Tablets Industry Drivers
  3. 2.3 Filgotinib Tablets Industry Opportunities and Challenges
  4. 2.4 Filgotinib Tablets Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Filgotinib Tablets Revenue (2021-2026)
  2. 3.2 Global Top Players by Filgotinib Tablets Sales (2021-2026)
  3. 3.3 Global Top Players by Filgotinib Tablets Price (2021-2026)
  4. 3.4 Global Filgotinib Tablets Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Filgotinib Tablets Major Company Production Sites & Headquarters
  6. 3.6 Global Filgotinib Tablets Company, Product Type & Application
  7. 3.7 Global Filgotinib Tablets Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Filgotinib Tablets Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Filgotinib Tablets Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Filgotinib Tablets Tier 1, Tier 2, and Tier 3
4 Filgotinib Tablets Regional Status and Outlook
  1. 4.1 Global Filgotinib Tablets Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Filgotinib Tablets Historic Market Size by Region
  3. 4.2.1 Global Filgotinib Tablets Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Filgotinib Tablets Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Filgotinib Tablets Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Filgotinib Tablets Forecasted Market Size by Region
  7. 4.3.1 Global Filgotinib Tablets Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Filgotinib Tablets Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Filgotinib Tablets Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Filgotinib Tablets by Application
  1. 5.1 Filgotinib Tablets Market by Application
  2. 5.1.1 Hospital Pharmacy
  3. 5.1.2 Online Pharmacy
  4. 5.1.3 Retail Pharmacy
  5. 5.2 Global Filgotinib Tablets Market Size by Application
  6. 5.2.1 Global Filgotinib Tablets Market Size Overview by Application (2021-2032)
  7. 5.2.2 Global Filgotinib Tablets Historic Market Size Review by Application (2021-2026)
  8. 5.2.3 Global Filgotinib Tablets Forecasted Market Size by Application (2027-2032)
  9. 5.3 Key Regions Market Size by Application
  10. 5.3.1 North America Filgotinib Tablets Sales Breakdown by Application (2021-2026)
  11. 5.3.2 Europe Filgotinib Tablets Sales Breakdown by Application (2021-2026)
  12. 5.3.3 Asia-Pacific Filgotinib Tablets Sales Breakdown by Application (2021-2026)
  13. 5.3.4 South America Filgotinib Tablets Sales Breakdown by Application (2021-2026)
  14. 5.3.5 Middle East and Africa Filgotinib Tablets Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Alfasigma
  2. 6.1.1 Alfasigma Company Information
  3. 6.1.2 Alfasigma Business Overview
  4. 6.1.3 Alfasigma Filgotinib Tablets Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Alfasigma Filgotinib Tablets Product Portfolio
  6. 6.1.5 Alfasigma Recent Developments
  7. 6.2 Gilead Sciences
  8. 6.2.1 Gilead Sciences Company Information
  9. 6.2.2 Gilead Sciences Business Overview
  10. 6.2.3 Gilead Sciences Filgotinib Tablets Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Gilead Sciences Filgotinib Tablets Product Portfolio
  12. 6.2.5 Gilead Sciences Recent Developments
  13. 6.3 Eisai
  14. 6.3.1 Eisai Company Information
  15. 6.3.2 Eisai Business Overview
  16. 6.3.3 Eisai Filgotinib Tablets Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Eisai Filgotinib Tablets Product Portfolio
  18. 6.3.5 Eisai Recent Developments
7 North America by Country
  1. 7.1 North America Filgotinib Tablets Sales by Country
  2. 7.1.1 North America Filgotinib Tablets Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Filgotinib Tablets Sales by Country (2021-2026)
  4. 7.1.3 North America Filgotinib Tablets Sales Forecast by Country (2027-2032)
  5. 7.2 North America Filgotinib Tablets Market Size by Country
  6. 7.2.1 North America Filgotinib Tablets Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Filgotinib Tablets Market Size by Country (2021-2026)
  8. 7.2.3 North America Filgotinib Tablets Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Filgotinib Tablets Sales by Country
  2. 8.1.1 Europe Filgotinib Tablets Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Filgotinib Tablets Sales by Country (2021-2026)
  4. 8.1.3 Europe Filgotinib Tablets Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Filgotinib Tablets Market Size by Country
  6. 8.2.1 Europe Filgotinib Tablets Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Filgotinib Tablets Market Size by Country (2021-2026)
  8. 8.2.3 Europe Filgotinib Tablets Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Filgotinib Tablets Sales by Country
  2. 9.1.1 Asia-Pacific Filgotinib Tablets Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Filgotinib Tablets Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Filgotinib Tablets Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Filgotinib Tablets Market Size by Country
  6. 9.2.1 Asia-Pacific Filgotinib Tablets Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Filgotinib Tablets Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Filgotinib Tablets Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Filgotinib Tablets Sales by Country
  2. 10.1.1 South America Filgotinib Tablets Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Filgotinib Tablets Sales by Country (2021-2026)
  4. 10.1.3 South America Filgotinib Tablets Sales Forecast by Country (2027-2032)
  5. 10.2 South America Filgotinib Tablets Market Size by Country
  6. 10.2.1 South America Filgotinib Tablets Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Filgotinib Tablets Market Size by Country (2021-2026)
  8. 10.2.3 South America Filgotinib Tablets Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Filgotinib Tablets Sales by Country
  2. 11.1.1 Middle East and Africa Filgotinib Tablets Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Filgotinib Tablets Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Filgotinib Tablets Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Filgotinib Tablets Market Size by Country
  6. 11.2.1 Middle East and Africa Filgotinib Tablets Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Filgotinib Tablets Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Filgotinib Tablets Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Filgotinib Tablets Value Chain Analysis
  2. 12.1.1 Filgotinib Tablets Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Filgotinib Tablets Production Mode & Process
  7. 12.2 Filgotinib Tablets Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Filgotinib Tablets Distributors
  10. 12.2.3 Filgotinib Tablets Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research